Skip to main content

Beat the rush! Make sure to use your benefits before they expire at the end of the year.

As part of our COVID-19 protocol we are now requiring our patients to undergo an Optomap Retinal exam in lieu of dilation to evaluate the inside lining of the eye. This procedure is being performed to lessen the time spent in our office. There is an additional fee of $35.00 for this test which is often not covered by insurance plans as it is considered a health screening. However, it can be billed to a medical insurance plan if there is a retinal disease diagnosis. Please speak to our staff for more information.

dr.Warstadt Logo

Anniversary WhiteEmblem Transparent

Treatment for Diabetic Retinopathy

95% of people diagnosed with diabetic retinopathy, if treated promptly, can avoid significant vision loss.

Laser photocoagulation treatment seals off blood vessels that are leaking into the eye, and stops new blood vessels from growing. This laser treatment only takes a few moments, and is painless.

Sometimes in diabetic retinopathy blood leaks into the vitreous humor in the eye, clouding vision. Some eye doctors wait before choosing treatment, as the blood may dissipate by itself. Another treatment option is a vitrectomy, which removes blood that has already leaked into the vitreous humor.

To improve the supply of blood to the core inner portion of the retina, a laser may be used to destroy tissue on the outside of the retina which is not essential for basic vision. This procedure is used to save vision.

Lucentis is a medication that is administered by an eye doctor using injections. This medication was approved by the FDA is 2015, and is the first non-laser treatment approved by the FDA. The FDA is currently reviewing several other non-laser treatments for diabetic retinopathy.